High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery

Critical Care

Volumn 15, Issue 3, 2011, Pages

  Ricci, Zaccaria ^a   Luciano, Rosa ^a   Favia, Isabella ^a   Garisto, Cristiana ^a   Muraca, Maurizio ^a   Morelli, Stefano ^a   Di Chiara, Luca ^a   Cogo, Paola ^a   Picardo, Sergio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; FENOLDOPAM; FUROSEMIDE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHENTOLAMINE; PLACEBO; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOPULMONARY BYPASS; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFANT; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; ORGAN PERFUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PULMONARY VALVE ATRESIA; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RISK FACTOR; SCORING SYSTEM; URINE VOLUME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CYSTATIN C; DOUBLE-BLIND METHOD; FENOLDOPAM; HUMANS; INFANT; LIPOCALINS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS;

EID: 79959679839     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10295     Document Type: Article

References (37)

1. Miller A, Lu CK, Wang S, Umstead TM, Freeman WM, Vrana K, Yang S, Myers JL, Phelps DS, Zahn JD, Undar A. Pediatric cardiopulmonary bypass circuits: a review of studies conducted at the Penn State Pediatric Cardiac Research Laboratories. J Extra Corpor Technol 2009, 41:P50-P58.
2. Murphy GS, Hessel EA, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009, 108:1394-1417. 10.1213/ane.0b013e3181875e2e, 19372313.
3. Chiravuri SD, Riegger LQ, Christensen R, Butler RR, Malviya S, Tait AR, Voepel-Lewis T. Factors associated with acute kidney injury or failure in children undergoing cardiopulmonary bypass: a case-controlled study. Paediatr Anaesth 2011, 21:880-886. 10.1111/j.1460-9592.2011.03532.x, 21306475, 21306475.
4. Sirvinskas E, Andrejaitiene J, Raliene L, Nasvytis L, Karbonskiene A, Pilvinis V, Sakalauskas J. Cardiopulmonary bypass management and acute renal failure: risk factors and prognosis. Perfusion 2008, 23:323-327. 10.1177/0267659109105251, 19454560.
5. Zappitelli M, Bernier PL, Saczkowski RS, Tchervenkov CI, Gottesman R, Dancea A, Hyder A, Alkandari O. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 2009, 76:885-892. 10.1038/ki.2009.270, 19641482.
6. Fleming F, Bohn D, Edwards H, Cox P, Geary D, McCrindle BW, Williams WG. Renal replacement therapy after repair of congenital heart disease in children: a comparison of hemofiltration and peritoneal dialysis. J Thorac Cardiovasc Surg 1995, 109:322-331. 10.1016/S0022-5223(95)70394-2, 7853885.
7. Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2007, 2:732-738. 10.2215/CJN.03200906, 17699489.
8. Sirvinskas E, Andrejaitiene J, Raliene L, Nasvytis L, Karbonskiene A, Pilvinis V, Sakalauskas J. Cardiopulmonary bypass management and acute renal failure: risk factors and prognosis. Perfusion 2008, 23:323-327. 10.1177/0267659109105251, 19454560.
9. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol 2010, 55:2024-2033. 10.1016/j.jacc.2009.12.046, 20447525.
10. Ranucci M, Romitti F, Isgrò G, Cotza M, Brozzi S, Boncilli A, Ditta A. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg 2005, 80:2213-2220. 10.1016/j.athoracsur.2005.05.069, 16305874.
11. Markowitz SD, Greeley WJ. Cardiopulmonary bypass. Anesthesia for Congenital Heart Disease 2005, 64-81. Boston, Mass., USA: Blackwell Publishing, Andropulos DB, Layer SA, Russel IA, 1.
12. Al-Ismaili Z, Palijan A, Zappitelli M. Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol 2011, 26:29-40. 10.1007/s00467-010-1576-0, 20623143.
13. Uchino S. Creatinine. Curr Opin Crit Care 2010,
14. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery: a prospective cohort study. Crit Care Med 2009, 37:553-560. 10.1097/CCM.0b013e318195846e, 19114878.
15. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238. 10.1016/S0140-6736(05)74811-X, 15811456.
16. Haase M, Bellomo R, Haase-Fielitz A. Neutrophil gelatinase-associated lipocalin. Curr Opin Crit Care 2010,
17. Bagshaw SM, Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit Care 2010,
18. Köner O, Tekin S, Köner A, Soybir N, Seren S, Karaoglu K. Effects of phentolamine on tissue perfusion in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1999, 13:191-197. 10.1016/S1053-0770(99)90086-1, 10230955.
19. Tweddell JS, Hoffman GM, Fedderly RT, Berger S, Thomas JP, Ghanayem NS, Kessel MW, Litwin SB. Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg 1999, 67:161-167. 10.1016/S0003-4975(98)01266-1, 10086542.
20. Tuǧrul M, Pembeci K, Camci E, Ozkan T, Telci L. Comparison of the effects of sodium nitroprusside and isoflurane during rewarming on cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997, 11:712-717. 10.1016/S1053-0770(97)90163-4, 9327311.
21. Kaya K, Oǧuz M, Akar AR, Durdu S, Aslan A, Erturk S, Taşöz R, Ozyurda U. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 2007, 31:290-297. 10.1016/j.ejcts.2006.11.015, 17174559.
22. Picca S, Ricci Z, Picardo S. Acute kidney injury in an infant after cardiopulmonary bypass. Semin Nephrol 2008, 28:470-476. 10.1016/j.semnephrol.2008.05.006, 18790366.
23. van der Vorst MM, Ruys-Dudok van Heel I, Kist-van Holthe JE, den Hartigh J, Schoemaker RC, Cohen AF, Burggraaf J. Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery. Intensive Care Med 2001, 27:711-715. 10.1007/s001340000819, 11398698.
24. Tumlin JA. Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy. Curr Opin Crit Care 2009, 15:514-519. 10.1097/MCC.0b013e328332f6f9, 19829105.
25. Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005, 111:3230-3235. 10.1161/CIRCULATIONAHA.104.509141, 15967861.
26. Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G, Calabrò MG, Sheiban I, Tumlin JA, Ranucci M, Zangrillo A. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2008, 22:27-33. 10.1053/j.jvca.2007.07.015, 18249327.
27. Moffett BS, Mott AR, Nelson DP, Goldstein SL, Jefferies JL. Renal effects of fenoldopam in critically ill pediatric patients: a retrospective review. Pediatr Crit Care Med 2008, 9:403-406. 10.1097/PCC.0b013e3181728c25, 18496409.
28. Costello JM, Thiagarajan RR, Dionne RE, Allan CK, Booth KL, Burmester M, Wessel DL, Laussen PC. Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 2006, 7:28-33. 10.1097/01.PCC.0000194046.47306.FB, 16395071.
29. Meco M, Cirri S. The effect of various fenoldopam doses on renal perfusion in patients undergoing cardiac surgery. Ann Thorac Surg 2010, 89:497-550. 10.1016/j.athoracsur.2009.09.071, 20103330.
30. Ricci Z, Stazi GV, Di Chiara L, Morelli S, Vitale V, Giorni C, Ronco C, Picardo S. Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial. Interact Cardiovasc Thorac Surg 2008, 7:1049-1053. 10.1510/icvts.2008.185025, 18782787.
31. Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR. Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 2008, 6:8-16.
32. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007, 71:1028-1035. 10.1038/sj.ki.5002231, 17396113.
33. Shore S, Nelson D, Pearl J, Manning P, Wong H, Shanley T, Keyser T, Schwartz S. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 2001, 88:591-594. 10.1016/S0002-9149(01)01751-9, 11524081.
34. Jenkins KJ. Risk adjustment for congenital heart surgery: the RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004, 7:180-184. 10.1053/j.pcsu.2004.02.009, 15283367.
35. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, . for the NGAL Meta-analysis Investigator Group Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024. 10.1053/j.ajkd.2009.07.020, 19850388, for the NGAL Meta-analysis Investigator Group.
36. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011, 57:1752-1761. 10.1016/j.jacc.2010.11.051, 21511111.
37. Ranucci M, De Benedetti D, Bianchini C, Castelvecchio S, Ballotta A, Frigiola A, Menicanti L. Effects of fenoldopam infusion in complex cardiac surgical operations: a prospective, randomized, double-blind, placebo-controlled study. Minerva Anestesiol 2010, 76:249-259.